Xvivo Perfusion Pink Sheet Forecast - Naive Prediction
| XVIPYDelisted Stock | USD 5.70 0.53 8.51% |
The Naive Prediction forecasted value of Xvivo Perfusion AB on the next trading day is expected to be 4.92 with a mean absolute deviation of 0.35 and the sum of the absolute errors of 21.10. Xvivo Pink Sheet Forecast is based on your current time horizon.
At this time the relative strength index (rsi) of Xvivo Perfusion's share price is below 20 . This entails that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Xvivo Perfusion hype-based prediction, you can estimate the value of Xvivo Perfusion AB from the perspective of Xvivo Perfusion response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Xvivo Perfusion AB on the next trading day is expected to be 4.92 with a mean absolute deviation of 0.35 and the sum of the absolute errors of 21.10. Xvivo Perfusion after-hype prediction price | USD 5.7 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Xvivo |
Xvivo Perfusion Additional Predictive Modules
Most predictive techniques to examine Xvivo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Xvivo using various technical indicators. When you analyze Xvivo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Xvivo Perfusion Naive Prediction Price Forecast For the 24th of January
Given 90 days horizon, the Naive Prediction forecasted value of Xvivo Perfusion AB on the next trading day is expected to be 4.92 with a mean absolute deviation of 0.35, mean absolute percentage error of 0.21, and the sum of the absolute errors of 21.10.Please note that although there have been many attempts to predict Xvivo Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Xvivo Perfusion's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Xvivo Perfusion Pink Sheet Forecast Pattern
| Backtest Xvivo Perfusion | Xvivo Perfusion Price Prediction | Buy or Sell Advice |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Xvivo Perfusion pink sheet data series using in forecasting. Note that when a statistical model is used to represent Xvivo Perfusion pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 116.5434 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.346 |
| MAPE | Mean absolute percentage error | 0.0392 |
| SAE | Sum of the absolute errors | 21.103 |
Predictive Modules for Xvivo Perfusion
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Xvivo Perfusion AB. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Xvivo Perfusion After-Hype Price Prediction Density Analysis
As far as predicting the price of Xvivo Perfusion at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Xvivo Perfusion or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Xvivo Perfusion, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Xvivo Perfusion Estimiated After-Hype Price Volatility
In the context of predicting Xvivo Perfusion's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Xvivo Perfusion's historical news coverage. Xvivo Perfusion's after-hype downside and upside margins for the prediction period are 5.70 and 5.70, respectively. We have considered Xvivo Perfusion's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Xvivo Perfusion is very steady at this time. Analysis and calculation of next after-hype price of Xvivo Perfusion AB is based on 3 months time horizon.
Xvivo Perfusion Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Xvivo Perfusion is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Xvivo Perfusion backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Xvivo Perfusion, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Any time |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
5.70 | 5.70 | 0.00 |
|
Xvivo Perfusion Hype Timeline
Xvivo Perfusion AB is at this time traded for 5.70. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Xvivo is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Xvivo Perfusion is about 0.0%, with the expected price after the next announcement by competition of 5.70. The company had not issued any dividends in recent years. Assuming the 90 days horizon the next projected press release will be any time. Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.Xvivo Perfusion Related Hype Analysis
Having access to credible news sources related to Xvivo Perfusion's direct competition is more important than ever and may enhance your ability to predict Xvivo Perfusion's future price movements. Getting to know how Xvivo Perfusion's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Xvivo Perfusion may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| EBRCZ | EBR Systems | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| TRSSF | Terrascend Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| AIHLF | Adcock Ingram Holdings | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CKDXF | Opthea | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PKBFF | PeakBirch Logic | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SSII | SS Innovations International | 0.00 | 0 per month | 0.00 | (0.17) | 7.43 | (7.18) | 17.59 | |
| KDGTF | Kindstar Global Technology | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CCHWF | Columbia Care | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SPMXF | Supermax Berhad | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PEXXF | PT Tempo Scan | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Xvivo Perfusion Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Xvivo Perfusion pink sheet to make a market-neutral strategy. Peer analysis of Xvivo Perfusion could also be used in its relative valuation, which is a method of valuing Xvivo Perfusion by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Xvivo Perfusion Market Strength Events
Market strength indicators help investors to evaluate how Xvivo Perfusion pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Xvivo Perfusion shares will generate the highest return on investment. By undertsting and applying Xvivo Perfusion pink sheet market strength indicators, traders can identify Xvivo Perfusion AB entry and exit signals to maximize returns.
Story Coverage note for Xvivo Perfusion
The number of cover stories for Xvivo Perfusion depends on current market conditions and Xvivo Perfusion's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Xvivo Perfusion is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Xvivo Perfusion's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in Xvivo Pink Sheet
If you are still planning to invest in Xvivo Perfusion AB check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Xvivo Perfusion's history and understand the potential risks before investing.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |